Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Rathelot

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 6, 2011
Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assayRaymond Calaf, Claire Cerini, Cécile Génovésio, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose GelEdouard Lamy, Caroline Orneto, Oumil Her Abdou Ali, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-<i>a</i>]pyridine Antileishmanial PharmacophoreRomain Paoli-Lombardo, Nicolas Primas, Sandra Bourgeade-Delmas, et al.
European Journal of Medicinal Chemistry|August 10, 2018
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductasesCyril Fersing, Clotilde Boudot, Julien Pedron, et al.
European Journal of Medicinal Chemistry|March 21, 2015
Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of PlasmodiumAnita Cohen, Peggy Suzanne, Jean-Charles Lancelot, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Nongenotoxic 3-Nitroimidazo[1,2-<i>a</i>]pyridines Are NTR1 Substrates That Display Potent <i>in Vitro</i> Antileishmanial ActivityCyril Fersing, Louise Basmaciyan, Clotilde Boudot, et al.
European Journal of Medicinal Chemistry|August 16, 2020
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic propertiesCyril Fersing, Clotilde Boudot, Romain Paoli-Lombardo, et al.
European Journal of Medicinal Chemistry|July 12, 2020
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruziCyril Fersing, Clotilde Boudot, Caroline Castera-Ducros, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 6, 2011
Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assayRaymond Calaf, Claire Cerini, Cécile Génovésio, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose GelEdouard Lamy, Caroline Orneto, Oumil Her Abdou Ali, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-<i>a</i>]pyridine Antileishmanial PharmacophoreRomain Paoli-Lombardo, Nicolas Primas, Sandra Bourgeade-Delmas, et al.
European Journal of Medicinal Chemistry|August 10, 2018
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductasesCyril Fersing, Clotilde Boudot, Julien Pedron, et al.
European Journal of Medicinal Chemistry|March 21, 2015
Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of PlasmodiumAnita Cohen, Peggy Suzanne, Jean-Charles Lancelot, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Nongenotoxic 3-Nitroimidazo[1,2-<i>a</i>]pyridines Are NTR1 Substrates That Display Potent <i>in Vitro</i> Antileishmanial ActivityCyril Fersing, Louise Basmaciyan, Clotilde Boudot, et al.
European Journal of Medicinal Chemistry|August 16, 2020
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic propertiesCyril Fersing, Clotilde Boudot, Romain Paoli-Lombardo, et al.
European Journal of Medicinal Chemistry|July 12, 2020
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruziCyril Fersing, Clotilde Boudot, Caroline Castera-Ducros, et al.
Pageof 5